(Q48375460)

11 February 2018

title

Tissue inhibitors of matrix metalloproteinases are elevated in cerebrospinal fluid of neurodegenerative diseases. (English)

1 reference

11 February 2018

0 references

1 reference

Lorenzl S

1

1 reference

11 February 2018

Albers DS

2

1 reference

11 February 2018

LeWitt PA

3

1 reference

11 February 2018

Chirichigno JW

4

1 reference

11 February 2018

Hilgenberg SL

5

1 reference

11 February 2018

Cudkowicz ME

6

1 reference

11 February 2018

Beal MF

7

1 reference

11 February 2018

publication date

1 March 2003

1 reference

11 February 2018

Journal of the Neurological Sciences

published in

1 reference

11 February 2018

volume

207

1 reference

11 February 2018

issue

1-2

1 reference

11 February 2018

page(s)

71-76

1 reference

11 February 2018

Matrix metalloproteinase-9 (MMP-9) is synthesized in neurons of the human hippocampus and is capable of degrading the amyloid-beta peptide (1-40).

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900398-2

Dexamethasone regulation of matrix metalloproteinase expression in CNS vascular endothelium.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900398-2

Regulation of matrix metalloproteinase expressions in astrocytes, microglia and neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900398-2

Matrix metalloproteinases and diseases of the CNS.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900398-2

Tissue inhibitors of metalloproteinases: evolution, structure and function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900398-2

Matrix metalloproteinases and tissue inhibitors of metalloproteinases in viral meningitis: upregulation of MMP-9 and TIMP-1 in cerebrospinal fluid.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900398-2

Matrix metalloproteinases contribute to the blood-brain barrier disruption during bacterial meningitis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900398-2

Increased gelatinase A (MMP-2) and gelatinase B (MMP-9) activities in human brain after focal ischemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900398-2

Matrix metalloproteinase-9 (gelatinase B) is selectively elevated in CSF during relapses and stable phases of multiple sclerosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900398-2

Localization of tissue inhibitor of matrix metalloproteinases in Alzheimer's disease and normal brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900398-2

Matrix metalloproteinase-9 is elevated in serum of patients with amyotrophic lateral sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900398-2

Matrix metalloproteinase-9 (MMP-9) in human cerebrospinal fluid (CSF): elevated levels are primarily related to CSF cell count

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900398-2

Parkinsonism: onset, progression, and mortality

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900398-2

El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases a

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900398-2

Quantitative zymography: detection of picogram quantities of gelatinases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900398-2

Specific matrix metalloproteinase profiles in the cerebrospinal fluid correlated with the presence of malignant astrocytomas, brain metastases, and carcinomatous meningitis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900398-2

Matrix metalloproteinases in the cerebrospinal fluid of patients with Lyme neuroborreliosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900398-2

Gelatinase B: a tuner and amplifier of immune functions.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900398-2

Characterization of Neutral Proteinases from Alzheimer-Affected and Control Brain Specimens: Identification of Calcium-Dependent Metalloproteinases from the Hippocampus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900398-2

Characterization of metalloproteinases and tissue inhibitors of metalloproteinases in human plasma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900398-2

Tissue inhibitor of metalloproteinases-1 (TIMP-1) is differentially induced in neurons and astrocytes after seizures: evidence for developmental, immediate early gene, and lesion response.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900398-2

Differential regulation of tissue inhibitor of metalloproteinase mRNA expression in response to intracranial injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900398-2

Basement membrane and repair of injury to peripheral nerve: defining a potential role for macrophages, matrix metalloproteinases, and tissue inhibitor of metalloproteinases-1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900398-2

Reprogramming of TIMP-1 and TIMP-3 expression profiles in brain microvascular endothelial cells and astrocytes in response to proinflammatory cytokines.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900398-2

Degradation of interleukin 1beta by matrix metalloproteinases.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900398-2

Regulation of matrix metalloproteinase expression in human vein and microvascular endothelial cells. Effects of tumour necrosis factor alpha, interleukin 1 and phorbol ester

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900398-2

TIMP-2 reduces proteolytic opening of blood-brain barrier by type IV collagenase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900398-2

TIMP-2 over-expression reduces invasion and angiogenesis and protects B16F10 melanoma cells from apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900398-2

Matrix metalloproteinases in the normal human central nervous system, microglial nodules, and multiple sclerosis lesions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900398-2

Matrix metalloproteinases in the neocortex and spinal cord of amyotrophic lateral sclerosis patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900398-2

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0022-510X(02)00398-2

1 reference

11 February 2018

PubMed ID

12614934

1 reference

11 February 2018